Bill
A 2120
Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.
2026-2027 Regular Session
Introduced by Linda Carter and 3 co-sponsors
Forces NJ Medicaid inpatient psychiatric facilities to receive outpatient reimbursement rates for long-acting injectable antipsychotics, potentially reducing provider revenue while increasing medication access.
Introduced, Referred to Assembly Aging and Human Services Committee